Abstract
This study examines pharmaceutical research from a bibliometric perspective. It finds that there are bibliometric correlates of successful pharmaceutical research, in particular, the number and proportion of star (highly cited) clinical medical articles. The research also reveals that pharmaceutical company research reported in basic biomedical research journals is very highly cited, on a par with NIH supported medical school research. The policy implications of this are discussed. In addition, the pharmaceutical output (approved new drugs)/input (R&D budget) measures developed permit a ranking and characterization of the research performance of 24 major pharmaceutical companies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
